C-reactive protein and aetiological subtypes of cerebral infarction

被引:60
作者
Terruzzi, Alessandro [2 ]
Valente, Laura [1 ]
Mariani, Roberto [3 ]
Moschini, Luca
Camerlingo, Massimo [1 ]
机构
[1] Policlin San Marco, Neurol Unit, I-24040 Bergamo, Italy
[2] Policlin San Marco, Stroke Unit, Bergamo, Italy
[3] Policlin San Marco, Clin Chem Lab, Bergamo, Italy
关键词
stroke; cerebral ischaemia; C-reactive protein; aetiology of stroke;
D O I
10.1007/s10072-008-0975-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective We have sought to relate C-reactive protein (CRP), a peripheral marker of inflammation frequently elevated in stroke patients, with aetiology and prognosis of acute cerebral infarction. Patients and methods Patients were included after a first-ever CT/MR documented cerebral infarction. CRP was measured from blood samples taken within the 6th hour of the onset. Titres of C-reactive protein were stratified in quartiles. Aetiology of stroke was from TOAST criteria. Prognosis was mortality within 14 days of stroke. Results The study included 648 stroke patients. They were 335 women and 313 men, with a mean age of 70.3 years (median 72). CRP quartiles were mostly increased in cardioembolic strokes, After logistic regression analysis CRP remained an independent factor of 14-day mortality. Conclusions Our study suggests that in the acute phase of the cerebral infarction CRP might be either a marker of cardioembolism or a predictive factor for short-term mortality.
引用
收藏
页码:245 / 249
页数:5
相关论文
共 33 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   Using violet laser-induced chlorophyll fluorescence emission spectra for crop yield assessment of cowpea (Vigna unguiculata (L) Walp) varieties [J].
Anderson, B ;
Buah-Bassuah, PK ;
Tetteh, JP .
MEASUREMENT SCIENCE AND TECHNOLOGY, 2004, 15 (07) :1255-1265
[3]   Prognostic implications of admission inflammatory profile in acute ischemic neurological events [J].
Anuk, T ;
Assayag, EB ;
Rotstein, R ;
Fusman, R ;
Zeltser, D ;
Berliner, S ;
Avitzour, D ;
Shapira, I ;
Arber, N ;
Bornstein, NM .
ACTA NEUROLOGICA SCANDINAVICA, 2002, 106 (04) :196-199
[4]   CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION [J].
BAMFORD, J ;
SANDERCOCK, P ;
DENNIS, M ;
BURN, J ;
WARLOW, C .
LANCET, 1991, 337 (8756) :1521-1526
[5]   Inflammatory bio-markers and cardiovascular risk prediction [J].
Blake, GJ ;
Ridker, PM .
JOURNAL OF INTERNAL MEDICINE, 2002, 252 (04) :283-294
[6]   C-reactive protein (CRP) in cerebro-vascular events [J].
Canova, CR ;
Courtin, C ;
Reinhart, WH .
ATHEROSCLEROSIS, 1999, 147 (01) :49-53
[7]   Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis [J].
Chapman, CML ;
Beilby, JP ;
McQuillan, BM ;
Thompson, PL ;
Hung, J .
STROKE, 2004, 35 (07) :1619-1624
[8]   Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke - A statement for health care professionals from the CRP pooling project members [J].
Di Napoli, M ;
Schwaninger, M ;
Cappelli, R ;
Ceccarelli, E ;
Di Gianfilippo, G ;
Donati, C ;
Emsley, HCA ;
Forconi, S ;
Hopkins, SJ ;
Masotti, L ;
Muir, KW ;
Paciucci, A ;
Papa, F ;
Roncacci, S ;
Sander, D ;
Sander, K ;
Smith, CJ ;
Stefanini, A ;
Weber, D .
STROKE, 2005, 36 (06) :1316-1329
[9]   Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients [J].
Di Napoli, M ;
Papa, F .
STROKE, 2002, 33 (07) :1763-1771
[10]   C-reactive protein and outcome after first-ever ischemic stroke [J].
Di Napoli, M ;
Di Gianfilippo, G ;
Sollecito, A ;
Bocola, V .
STROKE, 2000, 31 (01) :238-239